Detection of prostate specific antigen (PSA)‎ in prostates patients

الملخص EN

The current study was carried out in Al-Sader teaching Hospital in Al-Najaf province during the period from 2017/1/8 till 2017/7/18.The study was undertaken to estimate the importance of PSA marker in differentiated between patients with prostate diseases and patients with prostate cancer.

The cases enrolled in this study included 210 patients with prostate diseases, their ages ranged from (21-89) years divided into sex group according to their ages.

60 apparently healthy male as a control subject, their age ranged from (20-80).

All 210 prostate patients had different serum PSA values from ≤2.5 (ng/ml) to >4.0 ng/ml.

94 (44.8%) had PSA > 4.0 ng/ml and 116 (55.2%) had PSA < 4.0 ng/ml.

38(43.2%) of patients with 60-69 years old had PSA level higher than the (4.0 ng/ml) while 27 (46.6%) of patients with 70-79 years old had PSA level higher than the (4.0 ng/ml) and the patients who had ≥ 80 years appears 10 (76.9%) of them had PSA level higher than the (4.0 ng/ml).

The results of this study revealed that Serum PSA level can be used as predictive and diagnostic marker for prostate cancer.